HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis.
Cancer metabolism
DTC
HERC5
Metastasis
Mitochondria
NSCLC
OXPHOS
Warburg effect
Journal
Journal of experimental & clinical cancer research : CR
ISSN: 1756-9966
Titre abrégé: J Exp Clin Cancer Res
Pays: England
ID NLM: 8308647
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
received:
14
12
2023
accepted:
20
03
2024
medline:
12
4
2024
pubmed:
12
4
2024
entrez:
11
4
2024
Statut:
epublish
Résumé
Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the "metastasis-suppressor" effect of HERC5, with a focus on mitochondrial metabolism pathways. We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO). To study early tumor cell dissemination, we used these cell line models in zebrafish experiments and performed intracardial injections in nude mice. Mass spectrometry (MS) was used to analyze protein changes in whole-cell extracts. Furthermore, electron microscopy (EM) imaging, cellular respiration, glycolytic activity, and lactate production were used to investigate the relationships with mitochondrial energy metabolism pathways. Using different in vitro NSCLC cell line models, we showed that NSCLC cells with low HERC5 expression had increased malignant and invasive properties. Furthermore, two different in vivo models in zebrafish and a xenograft mouse model showed increased dissemination and metastasis formation (in particular in the brain). Functional enrichment clustering of MS data revealed an increase in mitochondrial proteins in vitro when HERC5 levels were high. Loss of HERC5 leads to an increased Warburg effect, leading to improved adaptation and survival under prolonged inhibition of oxidative phosphorylation. Taken together, these results indicate that low HERC5 expression increases the metastatic potential of NSCLC in vitro and in vivo. Furthermore, HERC5-induced proteomic changes influence mitochondrial pathways, ultimately leading to alterations in energy metabolism and demonstrating its role as a new potential metastasis suppressor gene.
Sections du résumé
BACKGROUND
BACKGROUND
Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the "metastasis-suppressor" effect of HERC5, with a focus on mitochondrial metabolism pathways.
METHODS
METHODS
We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO). To study early tumor cell dissemination, we used these cell line models in zebrafish experiments and performed intracardial injections in nude mice. Mass spectrometry (MS) was used to analyze protein changes in whole-cell extracts. Furthermore, electron microscopy (EM) imaging, cellular respiration, glycolytic activity, and lactate production were used to investigate the relationships with mitochondrial energy metabolism pathways.
RESULTS
RESULTS
Using different in vitro NSCLC cell line models, we showed that NSCLC cells with low HERC5 expression had increased malignant and invasive properties. Furthermore, two different in vivo models in zebrafish and a xenograft mouse model showed increased dissemination and metastasis formation (in particular in the brain). Functional enrichment clustering of MS data revealed an increase in mitochondrial proteins in vitro when HERC5 levels were high. Loss of HERC5 leads to an increased Warburg effect, leading to improved adaptation and survival under prolonged inhibition of oxidative phosphorylation.
CONCLUSIONS
CONCLUSIONS
Taken together, these results indicate that low HERC5 expression increases the metastatic potential of NSCLC in vitro and in vivo. Furthermore, HERC5-induced proteomic changes influence mitochondrial pathways, ultimately leading to alterations in energy metabolism and demonstrating its role as a new potential metastasis suppressor gene.
Identifiants
pubmed: 38605423
doi: 10.1186/s13046-024-03020-z
pii: 10.1186/s13046-024-03020-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110Subventions
Organisme : Wilhelm Sander-Stiftung
ID : 2017.142.1
Organisme : Wilhelm Sander-Stiftung
ID : 2017.142.1
Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
pubmed: 33538338
doi: 10.3322/caac.21660
Wrage M, Hagmann W, Kemming D, Uzunoglu FG, Riethdorf S, Effenberger K, et al. Identification of HERC5 and its potential role in NSCLC progression. Int J Cancer. 2015;136(10):2264–72.
pubmed: 25353388
doi: 10.1002/ijc.29298
Xue F, Higgs BW, Huang J, Morehouse C, Zhu W, Yao X, et al. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. J Transl Med. 2015;11(13):379.
doi: 10.1186/s12967-015-0743-2
Zhu L, Wu J, Liu H. Downregulation of HERC5 E3 ligase attenuates the ubiquitination of CtBP1 to inhibit apoptosis in colorectal cancer cells. Carcinogenesis. 2021;42(8):1119–30.
pubmed: 34147029
doi: 10.1093/carcin/bgab053
Sala-Gaston J, Martinez-Martinez A, Pedrazza L, Lorenzo-Martín LF, Caloto R, Bustelo XR, et al. HERC Ubiquitin Ligases in Cancer. Cancers (Basel). 2020;12(6):1653.
pubmed: 32580485
doi: 10.3390/cancers12061653
Bhargava S, Patil V, Mahalingam K, Somasundaram K. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma. Oncotarget. 2017;8(10):16650–68.
pubmed: 28035070
doi: 10.18632/oncotarget.14287
Niu P, Yao B, Wei L, Zhu H, Fang C, Zhao Y. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia. Blood Cells Mol Dis. 2019;77:43–50.
pubmed: 30954792
doi: 10.1016/j.bcmd.2019.03.008
Tang J, Yang Q, Cui Q, Zhang D, Kong D, Liao X, et al. Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer. J Cell Physiol. 2020;235(1):394–407.
pubmed: 31225658
doi: 10.1002/jcp.28980
Wong JJY, Pung YF, Sze NSK, Chin KC. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A. 2006;103(28):10735–40.
pubmed: 16815975
pmcid: 1484417
doi: 10.1073/pnas.0600397103
Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem. 2006;281(7):4334–8.
pubmed: 16407192
doi: 10.1074/jbc.M512830200
Mathieu NA, Paparisto E, Barr SD, Spratt DE. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response. Viruses. 2021;13(6):1102.
pubmed: 34207696
pmcid: 8228270
doi: 10.3390/v13061102
Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16(7):423–39.
pubmed: 29769653
pmcid: 7097117
doi: 10.1038/s41579-018-0020-5
Zuo C, Sheng X, Ma M, Xia M, Ouyang L. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget. 2016;7(45):74393–409.
pubmed: 27626310
pmcid: 5342061
doi: 10.18632/oncotarget.11911
Han HG, Moon HW, Jeon YJ. ISG15 in cancer: Beyond ubiquitin-like protein. Cancer Lett. 2018;438:52–62.
pubmed: 30213559
doi: 10.1016/j.canlet.2018.09.007
Tecalco-Cruz AC. Molecular Pathways of Interferon-Stimulated Gene 15: Implications in Cancer. Curr Protein Pept Sci. 2021;22(1):19–28.
pubmed: 33292152
doi: 10.2174/1389203721999201208200747
Mirzalieva O, Juncker M, Schwartzenburg J, Desai S. ISG15 and ISGylation in human diseases. Cells. 2022;11(3):538.
pubmed: 35159348
pmcid: 8834048
doi: 10.3390/cells11030538
Alcalá S, Sancho P, Martinelli P, Navarro D, Pedrero C, Martín-Hijano L, et al. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity. Nat Commun. 2020;11(1):2682.
pubmed: 32472071
pmcid: 7260233
doi: 10.1038/s41467-020-16395-2
Baldanta S, Fernández-Escobar M, Acín-Perez R, Albert M, Camafeita E, Jorge I, et al. ISG15 governs mitochondrial function in macrophages following vaccinia virus infection. PLoS Pathog. 2017;13(10):e1006651.
pubmed: 29077752
pmcid: 5659798
doi: 10.1371/journal.ppat.1006651
Juncker M, Kim C, Reed R, Haas A, Schwartzenburg J, Desai S. ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells. Biochim Biophys Acta Mol Basis Dis. 2021;1867(6):166102.
pubmed: 33617986
doi: 10.1016/j.bbadis.2021.166102
Albert M, Bécares M, Falqui M, Fernández-Lozano C, Guerra S. ISG15, a small molecule with huge implications: regulation of mitochondrial homeostasis. Viruses. 2018;10(11):629.
pubmed: 30428561
pmcid: 6265978
doi: 10.3390/v10110629
Passaniti A, Kim MS, Polster BM, Shapiro P. Targeting mitochondrial metabolism for metastatic cancer therapy. Mol Carcinog. 2022;61(9):827–38.
pubmed: 35723497
pmcid: 9378505
doi: 10.1002/mc.23436
Vikramdeo KS, Sudan SK, Singh AP, Singh S, Dasgupta S. Mitochondrial respiratory complexes: Significance in human mitochondrial disorders and cancers. J Cell Physiol. 2022;237(11):4049–78.
pubmed: 36074903
doi: 10.1002/jcp.30869
di Gregorio J, Petricca S, Iorio R, Toniato E, Flati V. Mitochondrial and metabolic alterations in cancer cells. Eur J Cell Biol. 101(3):151225.
Scheid AD, Beadnell TC, Welch DR. Roles of mitochondria in the hallmarks of metastasis. Br J Cancer. 2021;124(1):124–35.
pubmed: 33144695
doi: 10.1038/s41416-020-01125-8
Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162–80.
pubmed: 33462499
pmcid: 8733955
doi: 10.1038/s41568-020-00320-2
Pouysségur J, Marchiq I, Parks SK, Durivault J, Ždralević M, Vucetic M. “Warburg effect” controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives. Semin Cancer Biol. 2022.
Felice DL, Sun J, Liu RH. A modified methylene blue assay for accurate cell counting. J Funct Foods. 2009;1(1):109–18.
doi: 10.1016/j.jff.2008.09.014
Hao W, Chang CPB, Tsao CC, Xu J. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem. 2010;285(17):12647–54.
pubmed: 20110356
pmcid: 2857128
doi: 10.1074/jbc.M109.084194
Guzmán C, Bagga M, Kaur A, Westermarck J, Abankwa D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS One. 2014;9(3):e92444.
pubmed: 24647355
pmcid: 3960247
doi: 10.1371/journal.pone.0092444
Choudhry P. High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection. PLoS One. 2016;11(2):e0148469.
pubmed: 26848849
pmcid: 4746068
doi: 10.1371/journal.pone.0148469
Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbeláez P, Cruz JC, Muñoz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 2020;15(7):e0232565.
pubmed: 32722676
pmcid: 7386569
doi: 10.1371/journal.pone.0232565
Paatero I, Alve S, Gramolelli S, Ivaska J, Ojala PM. Zebrafish Embryo Xenograft and Metastasis Assay. Bio Protoc. 2018;8(18):e3027.
pubmed: 34395813
pmcid: 8328589
doi: 10.21769/BioProtoc.3027
Loreth D, Schuette M, Zinke J, Mohme M, Piffko A, Schneegans S, et al. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis. Int J Mol Sci. 2021;22(13):6993.
pubmed: 34209696
pmcid: 8268634
doi: 10.3390/ijms22136993
Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, et al. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res. 2001;61(18):6624–8.
pubmed: 11559524
Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543–52.
pubmed: 34723319
doi: 10.1093/nar/gkab1038
Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, et al. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms. Nat Cancer. 2021;2(11):1224–42.
pubmed: 34870237
pmcid: 7612062
doi: 10.1038/s43018-021-00259-9
Bonnot T, Gillard M, Nagel D. A Simple Protocol for Informative Visualization of Enriched Gene Ontology Terms. Bio Protoc. 2019;9(22).
Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–4.
pubmed: 25964631
doi: 10.1093/bioinformatics/btv300
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14(1):128.
pubmed: 23586463
pmcid: 3637064
doi: 10.1186/1471-2105-14-128
Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A. Cell Profiler 4: improvements in speed, utility and usability. BMC Bioinformatics. 2021;22(1):433.
pubmed: 34507520
pmcid: 8431850
doi: 10.1186/s12859-021-04344-9
Sheng G, Gao Y, Wu H, Liu Y, Yang Y. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis. J Orthop Surg Res. 2023;18(1):131.
pubmed: 36814318
pmcid: 9948327
doi: 10.1186/s13018-023-03623-w
Qian Y, Galan-Cobo A, Guijarro I, Dang M, Molkentine D, Poteete A, et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell. 2023;41(7):1363-1380.e7.
pubmed: 37327788
doi: 10.1016/j.ccell.2023.05.015
Zhao M, Huang C, Yang L, Pan B, Yang S, Chang J, et al. SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma. Cell Death Dis. 2023;14(10):666.
pubmed: 37816756
pmcid: 10564934
doi: 10.1038/s41419-023-06208-x
Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene. 2008;27(33):4509–20.
pubmed: 18372910
doi: 10.1038/onc.2008.95
Liu Y, Murazzi I, Fuller AM, Pan H, Irizarry-Negron VM, DeVine A, et al. Sarcoma cells secrete hypoxia-modified collagen VI to weaken the lung endothelial barrier and promote metastasis. Cancer Res. 2024.
Sánchez-Tena S, Cubillos-Rojas M, Schneider T, Rosa JL. Functional and pathological relevance of HERC family proteins: a decade later. Cell Mol Life Sci. 2016;73(10):1955–68.
pubmed: 26801221
doi: 10.1007/s00018-016-2139-8
Hochrainer K, Mayer H, Baranyi U, Binder B, Lipp J, Kroismayr R. The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics. 2005;85(2):153–64.
pubmed: 15676274
doi: 10.1016/j.ygeno.2004.10.006
Garcia-Gonzalo FR, Rosa JL. The HERC proteins: functional and evolutionary insights. Cell Mol Life Sci. 2005;62(16):1826–38.
pubmed: 15968461
doi: 10.1007/s00018-005-5119-y
Oudshoorn D, van Boheemen S, Sánchez-Aparicio MT, Rajsbaum R, García-Sastre A, Versteeg GA. HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse Cells. PLoS One. 2012;7(1):e29870.
pubmed: 22272257
pmcid: 3260183
doi: 10.1371/journal.pone.0029870
Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmén J, Yekebas EF, et al. Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion. Clin Cancer Res. 2009;15(5):1566–74.
pubmed: 19208797
doi: 10.1158/1078-0432.CCR-08-2188
Herst PM, Rowe MR, Carson GM, Berridge MV. Functional mitochondria in health and disease. Front Endocrinol (Lausanne). 2017;8:296.
pubmed: 29163365
doi: 10.3389/fendo.2017.00296
Pernas L, Scorrano L. Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function. Annu Rev Physiol. 2016;78:505–31.
pubmed: 26667075
doi: 10.1146/annurev-physiol-021115-105011
Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene. 2013;32(40):4814–24.
pubmed: 23128392
doi: 10.1038/onc.2012.494
Sun X, Cao H, Zhan L, Yin C, Wang G, Liang P, et al. Mitochondrial fission promotes cell migration by Ca2+/CaMKII/ERK/FAK pathway in hepatocellular carcinoma. Liver Int. 2018;38(7):1263–72.
pubmed: 29210177
doi: 10.1111/liv.13660
Xie C, Wang FY, Sang Y, Chen B, Huang JH, He FJ, et al. Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis. Cancer Res. 2022;82(13):2431–43.
pubmed: 35544764
doi: 10.1158/0008-5472.CAN-21-3910
Chen P, Lu Y, He B, Xie T, Yan C, Liu T, et al. Rab32 promotes glioblastoma migration and invasion via regulation of ERK/Drp1-mediated mitochondrial fission. Cell Death Dis. 2023;14(3):198.
pubmed: 36922509
pmcid: 10017813
doi: 10.1038/s41419-023-05721-3
Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020;5(1):227.
pubmed: 33028824
pmcid: 7539288
doi: 10.1038/s41392-020-00311-7
Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, et al. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Investig. 2013;123(3):1068–81.
pubmed: 23426180
pmcid: 3582128
doi: 10.1172/JCI64264
Li LD, Sun HF, Liu XX, Gao SP, Jiang HL, Hu X, et al. Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism. PLoS One. 2015;10(12):e0144441.
pubmed: 26641458
pmcid: 4671602
doi: 10.1371/journal.pone.0144441
Marquez J, Kratchmarova I, Akimov V, Unda F, Ibarretxe G, Clerigué A, et al. NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells. Oncol Rep. 2018.
Agbor TA, Cheong A, Comerford KM, Scholz CC, Bruning U, Clarke A, et al. Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia. J Biol Chem. 2011;286(6):4718–26.
pubmed: 21123177
doi: 10.1074/jbc.M110.115931
Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, et al. Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells. Mol Cell Biol. 2001;21(10):3436–44.
pubmed: 11313469
pmcid: 100265
doi: 10.1128/MCB.21.10.3436-3444.2001
Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41(3):211–8.
pubmed: 26778478
pmcid: 4783224
doi: 10.1016/j.tibs.2015.12.001